Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-06-18

Clinical Trial Update: A Study Comparative of Formoterol/Fluticasone Foraseq® and Fluticasone in Asthma Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing Formoterol/Fluticasone (Foraseq) with Fluticasone in asthma patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluticasone propionate (Fluticasone propionate)
  • Foraseq

Snippet

Sponsor: Eurofarma Laboratorios S.A. | Conditions: Asthma | Phase 3 | Status: COMPLETED